Monte Rosa Therapeutics (GLUE) Revenue (2024 - 2026)
Monte Rosa Therapeutics (GLUE) posted quarterly Revenue of $4.3 million for Q1 2026, down 94.94% year-over-year from $84.9 million in Q1 2025, and up 54.62% quarter-over-quarter from $2.8 million in Q4 2025.
Monte Rosa Therapeutics (GLUE) Revenue (2024 - 2026) Analysis & Trends
Monte Rosa Therapeutics' Revenue history runs 3 years deep, the most recent figure standing at $4.3 million for Q1 2026.
- In Q1 2026, Revenue fell 94.94% year-over-year to $4.3 million; the TTM figure through Mar 2026 stood at $4.3 million (down 97.3% YoY), while the FY2025 annual figure was $123.7 million, up 63.54% from the prior year.
- Revenue for Q1 2026 stood at $4.3 million, up from $2.8 million in the prior quarter.
- The five-year high for Revenue was $150.0 million in Q3 2025, with the low at $1.1 million in Q1 2024.
- The 3-year median for Revenue is $9.2 million (2024), against an average of $50.9 million.
- Peak annual rise in Revenue reached 7882.05% in 2025, while the deepest fall reached 95.41% in 2025.
- Monte Rosa Therapeutics' Revenue stood at $60.6 million in 2024, then slumped by 95.41% to $2.8 million in 2025, then jumped by 54.62% to $4.3 million in 2026.
- Business Quant data shows GLUE's Revenue at $4.3 million in Q1 2026, $2.8 million in Q4 2025, and $150.0 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Monte Rosa Therapeutics | 1.32 Bn | 688.11 Mn | - | 8.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.97 Mn |
| Mar 31, 2026 | 4.30 Mn |
| Dec 31, 2025 | 2.78 Mn |
| Sep 30, 2025 | 150.00 Mn |
| Jun 30, 2025 | 140.20 Mn |
| Mar 31, 2025 | 84.93 Mn |
| Dec 31, 2024 | 60.65 Mn |
| Sep 30, 2024 | 9.22 Mn |
| Jun 30, 2024 | 4.70 Mn |
| Mar 31, 2024 | 1.06 Mn |